Unilateral Acute Idiopathic Blind Spot Enlargement following Second Dose of Covid-19 mRNA Vaccine

ABSTRACT

Acute idiopathic blind spot enlargement (AIBSE) is a rare condition which is poorly understood. To our knowledge, this is the first report of acute idiopathic blind spot enlargement following covid-19 vaccination. We believe there is educational value for ophthalmologists to recognize the potential association of ocular inflammation and new mRNA vaccines.

KEYWORDS:

• Acute idiopathic blind spot enlargement
• AIBSE
• Covid-19 vaccine

Disclosure statement

No potential conflict of interest was reported by the author(s).

SUPPLEMENTARY MATERIAL

Supplemental data for this article can be accessed online at https://doi.org/10.1080/09273948.2022.2090964

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.